Bart Corsaro
About Bart Corsaro
Bart Corsaro serves as the Director of Bio Analytics, Preclinical and Clinical Development at Ocugen, bringing extensive experience in vaccine development and laboratory compliance. He holds a Ph.D. in Molecular Virology and has held various leadership roles in prominent biotechnology companies, including GlaxoSmithKline and Wyeth Biotech.
Work at Ocugen
Bart Corsaro serves as the Director of BioAnalytics, Preclinical and Clinical Development at Ocugen, a position he has held since 2021. He is based in Malvern, Pennsylvania, United States. In this role, he focuses on bioanalytical processes that support both preclinical and clinical development efforts. His responsibilities include overseeing laboratory compliance and ensuring that analytical methods meet regulatory standards.
Education and Expertise
Bart Corsaro earned his Bachelor of Science in Biology from the University of Notre Dame, completing his studies from 1977 to 1981. He continued his education at the same institution, obtaining a Ph.D. in Molecular Virology from 1984 to 1987. Additionally, he achieved a Master of Science in Developmental Genetics from 1981 to 1984. His educational background supports his expertise in auditing laboratories for compliance with current Good Laboratory Practice (cGLP) and current Good Manufacturing Practice (cGMP) standards.
Background in Vaccine Development
Corsaro has extensive experience in the vaccine development field, having worked at GlaxoSmithKline Biologicals in various capacities. He served as the Global Vaccine Clinical Laboratory Portfolio Management and US Lead from 2010 to 2016. He later held the position of Vaccine Development Leader from 2016 to 2018 and was the PreClinical Lab Head for Human Immunology from 2018 to 2021. His roles involved managing clinical laboratory operations and ensuring compliance with regulatory standards.
Previous Experience at Wyeth Biotech
Before his tenure at GlaxoSmithKline Biologicals, Bart Corsaro worked at Wyeth Biotech from 1999 to 2010. His roles included Director of Quality Operations and Analytical Technology Transfer, as well as Director of Quality Product Leader. He also served as Associate Director/Director of Clinical Serology and Immunology. His experience at Wyeth Biotech contributed to his skills in large-scale tissue culture and assay validation.
Regulatory Compliance and Analytical Skills
Corsaro possesses significant skills in regulatory compliance, having completed Qualified Person (QP) training modules from David Beggs Associates in the UK. His expertise includes the evaluation and qualification of external laboratories to ensure they meet necessary standards for analytical work. He is experienced in assay validation following International Council for Harmonisation (ICH) guidelines, which is essential for developing reliable analytical methods.